Basic HTML-Version
204
Allgemein-, Viszeral- und Transplantationschirurgie
12.1 Publikationen 2010
1. Abiatari I, Esposito I, De Oliveira T, Felix K, Xin H,
Penzel R, Giese T, Friess H, Kleeff J:
Moesin-depen-
dent cytoskeleton remodeling is associated with an
anaplastic phenotype of pancreatic cancer J Cell
Mol Med 14(5):1166-79 IF 5,23
2. Alhamdani MS, Schröder C, Werner J, Giese NA,
Bauer A, Hoheisel JD.:
Single-Step Procedure for
the Isolation of Proteins at Near-Native Conditions
from Mammalian Tissue for Proteomic Analysis on
Antibody Microarrays. J Proteome Res. 9(2):963-71.
IF 5,13
3. Amann PM, Schadendorf D, Owen RW, Korn B,
Eichmüller SB, Bazhin AV:
Retinal and retinol are
potential regulators of gene expression in the kera-
tinocyte cell line HaCaT Exp Dermat IF 3,24
4. Antolovic D, Galindo L, Carstens A, Rahbari N,
Büchler MW, Weitz J, Koch M.:
Heterogeneous de-
tection of circulating tumor cells in patients with
colorectal cancer by immunomagnetic enrichment
using different EpCAM-specific antibodies BMC Bi-
otechnol. 28;10:35 IF 2,72
5. Bazhin AV, De Smet Ch, Golovastova MO, Schmidt
J, Philippov PP:
Aberrant demethylation of the re-
coverin gene is involved in the aberrant expression
of recoverin in cancer cells Exp Dermat 19; 1020-
1028 IF 3,24
6. Bazhin AV, Kahnert S, Kimpfler S, Schadendorf D,
Umansky V:
Distinct metabolism of cyclic adenosi-
ne monophosphate in regulatory and helper CD4+
T cells Mol Immunol 47; 678-684 IF 3,20
7. Beckhove P, Warta R, Lemke B, Stoycheva D, Mom-
burg F, Schnölzer M, Warnken U, Schmitz-Win-
nenthal H, Ahmadi R, Dyckhoff G, Bucur M, Jünger
S, Schueler T, Lennerz V, Woelfel T, Unterberg A,
Herold-Mende C:
Rapid T cell-based identification
of human tumor tissue antigens by automated two-
dimensional protein fractionation J Clin Invest.
120(6):2230-42 IF 16,59
8. Beermann J, Tetzlaff R, Bruckner T, Schöebinger M,
Müller-Stich BP, Gutt CN, Meinzer HP, Kadmon M,
Fischer L.:
Three-dimensional visualisation impro-
ves understanding of surgical liver anatomy. Med
Educ. 44(9):936-40. IF 2,70
9. Beller CJ, Gebhard MM, Karck M, Labrosse MR:
Usefulness and limitations of computational mo-
dels in aortic disease risk stratification J Vasc Surg.
52(6):1572-9 IF 3,52
10. Bergmann F, Moldenhauer G, Herpel E, Gaida
MM, Strobel O, Werner J, Esposito I, Müerkö-
ster SS, Schirmacher P, Kern MA.:
Expression of
L1CAM, COX-2, EGFR, c-KIT and Her2/neu in ana-
plastic pancreatic cancer: putative therapeutic
targets? Histopathology. 56(4):440-8. IF 3,86
11. Bergmann F, Singh S, Michel S, Kahler t C,
Schirmacher P, Helmke B, Von Knebel Doebe-
ritz M, Kloor M, Bläker H.:
Small bowel aden-
ocarcinomas in celiac disease follow the CIM-
MSI pathway. Oncol Rep. 24(6):1535-9
IF 1,59
12. Bergmann F, Wandschneider F, Sipos B, Molden-
hauer G, Schniewind B, Welsch T, Schirrmacher
P, Klöppel G, Altevogt P, Schäfer H, Sebens Mü-
erköster S.:
Elevated L1CAM expression in precur-
sor lesions and primary and metastastic tissues
of pancreatic ductal adenocarcinoma Oncol Rep.
24(4):909-15 IF 1,59
13. Blatner NR, Bonertz A, Beckhove P, Cheon EC,
Krantz SB, Strouch M, Weitz J, Koch M, Halver-
son AL, Bentrem DJ, Khazaie K.:
In colorectal
cancer mast cells contribute to systemic regula-
tory T-cell dysfunction. Proc Natl Acad Sci U S A.
107(14):6430-5. IF 9,43
14. Böcker U, Dinter D, Litterer C, Hummel F, Knebel
P, Franke A, Weiss C, Singer MV, Löhr JM.:
Com-
parison of magnetic resonance imaging and video
capsule enteroscopy in diagnosing small-bowel pa-
thology: Localization-dependent diagnostic yield.
Scand J Gastroenterol. 45(4):490-500 IF 2,08
15. Boeck S, Vehling-Kaiser U, Waldschmidt D, Kettner
E, Märten A, Winkelmann C, Klein S, Kojouharoff
G, Gauler T, Fischer von Weikersthal L, Clemens
MR, Geissler M, Greten TF, Hegewisch-Becker S,
Neugebauer S, Heinemann V:
Erlotinib 150 mg daily
plus chemotherapy in advanced pancreatic cancer:
an interim safety analysis of a multicenter, rando-
mized, cross-over phase III trial of the 'Arbeitsge-
meinschaft Internistische Onkologie' Anticancer
Drugs 21(1):94-100. IF 2,23
16. Bork U, Koch M, Büchler MW, Weitz J.:
Hepatobi-
liäre Tumorchirurgie. Indikation und Ausmaß der
Lymphknotendissektion Chirurg. 81(2):111-116 IF
0,60
17. Bork U, Koch M, Büchler MW, Weitz J.:
Wie viel
Betriebswir tschaf t braucht der Chirurg? Chirurg.
81(8):694, 696-700 IF 0,60
18. Bork U, Lee W, Kuchler A, Dittmar T, Thévenod F:
Cadmium-induced DNA damage triggers G(2)/M
arrest via chk1/2 and cdc2 in p53-deficient kidney
proximal tubule cells. Am. J. Physiol. Renal Physiol
298:F255-265 IF 3,73
19. Brenner T, Hofer S, Rosenhagen C, Steppan J, Lich-
tenstern C, Weitz J, Bruckner T, Lukic IK, Martin E,
Bierhaus A, Hoffmann U, Weigand MA.:
Macropha-
ge migration inhibitory factor (MIF) and manganese